期刊文献+

难治性精神分裂症不同亚型比较研究 被引量:1

Comparative studies of different subtypes of treatment-resistant schizophrenia
下载PDF
导出
摘要 目的探讨难治性精神分裂症不同亚型的临床特征。方法对116例难治性精神分裂症患者根据阳性与阴性症状量表中评分≥4分项目数的不同为标准,将患者分为阳性亚型组、阴性亚型组、混合型组进行比较分析。结果各组间比较差异有显著性(χ2=7.569,P=0.023)。阳性亚型组较其他组首发年龄大,总病程短,住院次数少,差异显著(P<0.01或P<0.05);混合型组较其他组用药种类多,差异显著(P<0.01或P<0.05);阳性亚型组急性或亚急性起病者显著多于其他组,阴性亚型组和混合型组起病慢性。结论阳性亚型组首发年龄较大,总病程较短;混合型组使用过的抗精神病药物种类较多;阴性亚型组和混合型组起病以慢性为主,住院次数也明显比阳性亚型组多。 Objective To explore the clinical features of different subtype of treatment-resistant schizophrenia. Methods 116 treatment-resistant schizophrenics were divided into positive, negative and mixed subtype group according to numbers of item's score ≥4 from the Positive And Negative Symptom Scale (PANSS). Results There were significant differences among the 3 groups(x^2=7. 569,P=0. 023). Compared with the mixed and negative subtype groups, age at first-onset was elder, total course of disease shorter and frequencies of hospitalization fewer in the positive subtype, differences were significant(P〈0. 01 or 〈0. 05) ; compared with the other 2 groups, kinds of taken drugs were more in the mixed group and differences significant(P〈0.01 or 〈0.05) ; numbers of patients who were acute or sub-acute onset in the positive group were more. Conclusion Age at first-onset was elder and total course of disease shorter in the positive group; kinds of taken drugs were more in the mixed group;onset of the mixed and negative groups were chronic and frequencies of hospitalization more.
机构地区 深圳市康宁医院
出处 《临床心身疾病杂志》 CAS 2005年第4期299-300,共2页 Journal of Clinical Psychosomatic Diseases
基金 广东省科学技术研究基金资助(编号A2002647)
关键词 难治性精神分裂症 亚型 阳性症状 阴性症状 Treatment-resistant schizophrenic subtype positive symptom negative symptom
  • 相关文献

参考文献7

二级参考文献28

  • 11.Kane J.Treatment-resistant schizophrenic patient.J Clin Psychiatry,1996,57(suppl 9):35
  • 24.Kane J,Honigfild G,Singer J,et al.Clozapine for the treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine.Arch Gen Psychiatry,1988,45:789
  • 35.Kane J.Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview.Br J Psychiatry,1992,160(suppl 17):41
  • 47.Marder SR,Meibach RC.Risperidone in the treatment of schizophrenia.Am J Psychiatry,1994,151:825
  • 58.Bondolfi G,Dufour H,Patris M,et al.Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study.Am J Psychiatry,1998,155:499
  • 69.Lieberman JA.Atypical antipsychotic drugs as a first line treatment of schizophrenia.J Clin Psychiatry,1996,57(suppl 11):68
  • 710.Marder SR.Management of treatment-resistant patient with schizophrenia.J Clin Psychiatry,1996,57(suppl 11):26
  • 8[1]Larsen TK, Friis D, Haahr U, et al. Early detection and intervention in first-episode schizophrenia. Acta Psychiatr Scand, 2001,103: 323.
  • 9[2]Stepherson J. Schizophrenia researchers striving for early detection and intervention. JAMA, 1999, 281:1877-1878.
  • 10[4]Phillips LJ, Yung AR, McGorry PD. Identification of young people at risk of psychosis: validation of personal assessment and crisis evaluation clinic intake criteria. Aust N Z J Psychiatry, 2000,34 (Suppl): 164-169.

共引文献153

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部